Bortezomib Sustains T Cell Function by Inducing miR-155-Mediated Downregulation of SOCS1 and SHIP1

Suppressive mechanisms operating within T cells are linked to immune dysfunction in the tumor microenvironment. We have previously reported using adoptive T cell immunotherapy models that tumor–bearing mice treated with a regimen of proteasome inhibitor, bortezomib - a dipeptidyl boronate, show incr...

Descripción completa

Detalles Bibliográficos
Autores principales: Renrick, Ariana N., Thounaojam, Menaka C., de Aquino, Maria Teresa P., Chaudhuri, Evan, Pandhare, Jui, Dash, Chandravanu, Shanker, Anil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946819/
https://www.ncbi.nlm.nih.gov/pubmed/33717088
http://dx.doi.org/10.3389/fimmu.2021.607044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946819/
https://www.ncbi.nlm.nih.gov/pubmed/33717088
http://dx.doi.org/10.3389/fimmu.2021.607044

Ejemplares similares